Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 5, 1996, Pages 492-497

  Wong, Y Nancy ^a   Wong, Pancras C ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DRUG METABOLITE; EXP 3312; FUROSEMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONCENTRATION RESPONSE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; FEMALE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA HALF LIFE; RABBIT; RAT; RENOVASCULAR HYPERTENSION;

ADMINISTRATION, ORAL; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPERTENSION, RENAL; IMIDAZOLES; INFUSIONS, INTRAVENOUS; MALE; MUSCLE CONTRACTION; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0029893424     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05960.x     Document Type: Article

References (11)

1. Christ, D. D., Wong, P. C., Wong, Y. N., Hart, S. D., Quon, C. Y., Lam, G. N. (1994) The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog. J. Pharmacol. Exp. Ther, 268: 1199-1205
2. DeNoble, V J., DeNoble, K. F, Spencer, K. R., Chiu, A. T., Wong, P. C., Timmermans, P. B. M. W. M. (1991) Non-peptide angiotensin II receptor antagonist and angiotensin converting enzyme inhibitor: effect on a rerun-induced deficit of a passive avoidance response in rats. Brain Res. 561: 230-235
3. Duncia, J. A., Carini, D. J., Chiu, A. T., Johnson, A. L., Price, W. A., Wong, P. C., Wexler, R. R., Timmermans, P. B. M. W. M. (1992) The discovery of DuP 753, a potent, orally active non-peptide angiotensin II receptor antagonist. Med. Res. Rev. 12: 149-191
4. Kenakin, T. P. (1987) Pharmacologic Analysis of Drug-Receptor Interactions, New York: Raven Press.
5. Timmermans, P. B. M. W. M., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. M., Smith, R. D. (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45: 205-251
6. Wong, P. C., Price, W. A., Chiu, A. T., Carini, D. J., Duncia, J. V., Wexler, R. R., Johnson, A. L., Timmermans, P. B. M. W. M.(1990a) Non-peptide angiotensin II receptor antagonists: studies with EXP9270 and DuP 753. Hypertension 15: 823-834
7. Wong, P. C., Price, W. A., Chiu, A. T., Carini, D. J., Duncia, J. V., Wexler, R. R, Johnson, A. L., Timmermans, P. B. M. W. M. (1990b) Non-peptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J. Pharmacol. Exp. Ther. 252: 719-725
8. Wong, P. C., Barnes, T. B., Chiu, A. T., Christ, D. D., Duncia, J. V., Herblin, W. F., Timmermans, P. B. M. W. M. (1991a) Losartan (DuP 753), an orally-active non-peptide angiotensin II receptor antagonist. Cardiovasc. Drug Rev. 9: 317-339
9. Wong, P. C., Hart, S. D., Duncia, J. V., Timmermans, P. B. M. W. M. (1991b) Non-peptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs. Eur. J. Pharmacol. 202: 323-330
10. Wong, P. C., Chiu, A. T., Duncia, J. V., Herblin, W. F., Timmermans, P. B. M. W. M. (1992) Angiotensin II receptor antagonists and receptor subtypes. Trends Endocrinol. Metab. 3: 211-217
11. Wong, Y. N., Burcham, D. L., Huang, S.-M., Quon, C. Y. (1993) Metabolism and disposition of EXP631-a novel antidepressant analgesic. Biopharm. Drug Dispos. 14: 519-531